LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
24h
Current
Min
11.15
Max
11.85
Recommendations | Buy |
---|---|
12 Months Forecast | +151.05% upside |
Past performance is not a reliable indicator of future results.
19 Dec 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 30 USD 151.05%
High 30 USD
Low 30 USD
Based on 1 Wall Street analysts offering 12 month price targets forMesoblast Ltd ADR - Dist in the last 3 months.
By TipRanks
Buy
1 ratings
1
Buy
0
Hold
0
Sell
Based on 1 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$